Cargando…

Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)

BACKGROUND: Retention in care is critical for children living with HIV taking antiretroviral therapy (ART). Loss to follow-up (LTFU) is high in HIV treatment programs in resource limited settings. We estimated the cumulative incidence of LTFU and identified associated risk factors among children on...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutanga, Jane N., Mutembo, Simon, Ezeamama, Amara E., Song, Xiao, Fubisha, Robert C., Mutesu-Kapembwa, Kunda, Sialondwe, Derrick, Simuchembu, Brenda, Chinyonga, Jelita, Thuma, Philip E., Whalen, Christopher C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694674/
https://www.ncbi.nlm.nih.gov/pubmed/31416432
http://dx.doi.org/10.1186/s12889-019-7374-0
_version_ 1783443876353146880
author Mutanga, Jane N.
Mutembo, Simon
Ezeamama, Amara E.
Song, Xiao
Fubisha, Robert C.
Mutesu-Kapembwa, Kunda
Sialondwe, Derrick
Simuchembu, Brenda
Chinyonga, Jelita
Thuma, Philip E.
Whalen, Christopher C.
author_facet Mutanga, Jane N.
Mutembo, Simon
Ezeamama, Amara E.
Song, Xiao
Fubisha, Robert C.
Mutesu-Kapembwa, Kunda
Sialondwe, Derrick
Simuchembu, Brenda
Chinyonga, Jelita
Thuma, Philip E.
Whalen, Christopher C.
author_sort Mutanga, Jane N.
collection PubMed
description BACKGROUND: Retention in care is critical for children living with HIV taking antiretroviral therapy (ART). Loss to follow-up (LTFU) is high in HIV treatment programs in resource limited settings. We estimated the cumulative incidence of LTFU and identified associated risk factors among children on ART at Livingstone Central Hospital (LCH), Zambia. METHODS: Using a retrospective cohort study design, we abstracted data from medical records of children who received ART between 2003 and 2015. Loss to follow-up was defined as no clinical and pharmacy contact for at least 90 days after the child missed their last scheduled clinical visit. Non-parametric competing risks models were used to estimate the cumulative incidence of death, LTFU and transfer. Cause-specific Cox regression was used to estimate the hazard ratios of the risk factors of LTFU. RESULTS: A total of 1039 children aged 0–15 years commenced ART at LCH between 2003 and 2015. Median duration of follow-up was 3.8 years (95% CI: 1.2–6.5), median age at ART initiation was 3.6 years (IQR: 1.3–8.6), 179 (17%) started treatment during their first year of life. At least 167 (16%) were LTFU and we traced 151 (90%). Of those we traced, 39 (26%) had died, 71 (47%) defaulted, 20 (13%) continued ART at other clinics and 21 (14%) continued treatment with gaps. The cumulative incidence of LTFU for the entire cohort was 2.7% (95% CI: 1.9–3.9) at 3 months, 4.1% (95% CI: 2.9–5.4) at 6 months and 14.1% (95% CI: 12.4–16.9) after 5 years on ART. Associated risk factors were: 1) non-disclosure of HIV status at baseline, aHR = 1.9 (1.2–2.9), 2) No phone ownership, aHR = 2.1 (1.6–2.9), 3) starting treatment between 2013 to 2015, aHR = 5.6 (2.2–14.1). CONCLUSION: Among the children LTFU mortality and default were substantially high. Children who started treatment in recent years (2013–2015) had the highest hazard of LTFU. Lack of access to a phone and non-disclosure of HIV-status to the index child was associated with higher hazards of LTFU. We recommend re-enforcement of client counselling and focused follow-up strategies using modern technology such as mobile phones as adjunct to current approaches.
format Online
Article
Text
id pubmed-6694674
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66946742019-08-19 Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) Mutanga, Jane N. Mutembo, Simon Ezeamama, Amara E. Song, Xiao Fubisha, Robert C. Mutesu-Kapembwa, Kunda Sialondwe, Derrick Simuchembu, Brenda Chinyonga, Jelita Thuma, Philip E. Whalen, Christopher C. BMC Public Health Research Article BACKGROUND: Retention in care is critical for children living with HIV taking antiretroviral therapy (ART). Loss to follow-up (LTFU) is high in HIV treatment programs in resource limited settings. We estimated the cumulative incidence of LTFU and identified associated risk factors among children on ART at Livingstone Central Hospital (LCH), Zambia. METHODS: Using a retrospective cohort study design, we abstracted data from medical records of children who received ART between 2003 and 2015. Loss to follow-up was defined as no clinical and pharmacy contact for at least 90 days after the child missed their last scheduled clinical visit. Non-parametric competing risks models were used to estimate the cumulative incidence of death, LTFU and transfer. Cause-specific Cox regression was used to estimate the hazard ratios of the risk factors of LTFU. RESULTS: A total of 1039 children aged 0–15 years commenced ART at LCH between 2003 and 2015. Median duration of follow-up was 3.8 years (95% CI: 1.2–6.5), median age at ART initiation was 3.6 years (IQR: 1.3–8.6), 179 (17%) started treatment during their first year of life. At least 167 (16%) were LTFU and we traced 151 (90%). Of those we traced, 39 (26%) had died, 71 (47%) defaulted, 20 (13%) continued ART at other clinics and 21 (14%) continued treatment with gaps. The cumulative incidence of LTFU for the entire cohort was 2.7% (95% CI: 1.9–3.9) at 3 months, 4.1% (95% CI: 2.9–5.4) at 6 months and 14.1% (95% CI: 12.4–16.9) after 5 years on ART. Associated risk factors were: 1) non-disclosure of HIV status at baseline, aHR = 1.9 (1.2–2.9), 2) No phone ownership, aHR = 2.1 (1.6–2.9), 3) starting treatment between 2013 to 2015, aHR = 5.6 (2.2–14.1). CONCLUSION: Among the children LTFU mortality and default were substantially high. Children who started treatment in recent years (2013–2015) had the highest hazard of LTFU. Lack of access to a phone and non-disclosure of HIV-status to the index child was associated with higher hazards of LTFU. We recommend re-enforcement of client counselling and focused follow-up strategies using modern technology such as mobile phones as adjunct to current approaches. BioMed Central 2019-08-15 /pmc/articles/PMC6694674/ /pubmed/31416432 http://dx.doi.org/10.1186/s12889-019-7374-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mutanga, Jane N.
Mutembo, Simon
Ezeamama, Amara E.
Song, Xiao
Fubisha, Robert C.
Mutesu-Kapembwa, Kunda
Sialondwe, Derrick
Simuchembu, Brenda
Chinyonga, Jelita
Thuma, Philip E.
Whalen, Christopher C.
Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
title Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
title_full Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
title_fullStr Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
title_full_unstemmed Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
title_short Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
title_sort predictors of loss to follow-up among children on long-term antiretroviral therapy in zambia (2003–2015)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694674/
https://www.ncbi.nlm.nih.gov/pubmed/31416432
http://dx.doi.org/10.1186/s12889-019-7374-0
work_keys_str_mv AT mutangajanen predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT mutembosimon predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT ezeamamaamarae predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT songxiao predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT fubisharobertc predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT mutesukapembwakunda predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT sialondwederrick predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT simuchembubrenda predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT chinyongajelita predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT thumaphilipe predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015
AT whalenchristopherc predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015